Femara 2.5mg Tablets contain letrozole, a hormone therapy medicine belonging to the aromatase inhibitor class. It works by reducing estrogen production in the body, helping slow the growth of certain hormone receptor-positive breast cancer cells.
Key Information
- Active Ingredient: Letrozole 2.5mg
- Class: Aromatase inhibitor
- Form: Film-coated tablets
- Uses: Used for certain cases of early, advanced or metastatic breast cancer in postmenopausal women.
- Common Side Effects: Hot flashes, sweating, joint or muscle pain, fatigue, dizziness, headache, nausea and changes in bone density may occur.
- Important: Femara should be used only as prescribed and under the supervision of a qualified healthcare professional.
Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Consult a qualified healthcare professional before starting or changing any medication.
